We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Alzheimer’s Patients Could Die From Risperdal: Study

Law360 (January 9, 2009, 12:00 AM EST) -- A new study has found that Alzheimer’s disease patients who take anti-psychotic drugs such as Johnson & Johnson's Risperdal may face a doubled risk of death, further bolstering concerns over a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.